Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric P Leip

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
Archives of Internal Medicine|May 9, 2002
Serum potassium and risk of cardiovascular disease: the Framingham heart studyCraig R Walsh, Martin G Larson, Eric P Leip, et al.
Hypertension (Dallas, Tex. : 1979)|November 17, 2004
Novel approach to examining first cardiovascular events after hypertension onsetDonald M Lloyd-Jones, Eric P Leip, Martin G Larson, et al.
JAMA|February 19, 2004
Predictors of new-onset kidney disease in a community-based populationCaroline S Fox, Martin G Larson, Eric P Leip, et al.
Circulation|September 29, 2004
Usefulness of exercise testing in the prediction of coronary disease risk among asymptomatic persons as a function of the Framingham risk scoreGary J Balady, Martin G Larson, Ramachandran S Vasan, et al.
Diabetes Care|September 28, 2005
Glycemic status and development of kidney disease: the Framingham Heart StudyCaroline S Fox, Martin G Larson, Eric P Leip, et al.
Circulation|June 25, 2003
Heritability and genetic linkage of plasma natriuretic peptide levelsThomas J Wang, Martin G Larson, Daniel Levy, et al.
Circulation|February 23, 2005
Predictors of new-onset diastolic and systolic hypertension: the Framingham Heart StudyStanley S Franklin, Jose R Pio, Nathan D Wong, et al.
JAMA|September 7, 2002
Plasma natriuretic peptides for community screening for left ventricular hypertrophy and systolic dysfunction: the Framingham heart studyRamachandran S Vasan, Emelia J Benjamin, Martin G Larson, et al.
Circulation|February 11, 2004
Impact of obesity on plasma natriuretic peptide levelsThomas J Wang, Martin G Larson, Daniel Levy, et al.
The American Journal of Cardiology|June 29, 2004
Framingham risk score and prediction of lifetime risk for coronary heart diseaseDonald M Lloyd-Jones, Peter W F Wilson, Martin G Larson, et al.
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Archives of Internal Medicine|May 9, 2002
Serum potassium and risk of cardiovascular disease: the Framingham heart studyCraig R Walsh, Martin G Larson, Eric P Leip, et al.
Hypertension (Dallas, Tex. : 1979)|November 17, 2004
Novel approach to examining first cardiovascular events after hypertension onsetDonald M Lloyd-Jones, Eric P Leip, Martin G Larson, et al.
JAMA|February 19, 2004
Predictors of new-onset kidney disease in a community-based populationCaroline S Fox, Martin G Larson, Eric P Leip, et al.
Circulation|September 29, 2004
Usefulness of exercise testing in the prediction of coronary disease risk among asymptomatic persons as a function of the Framingham risk scoreGary J Balady, Martin G Larson, Ramachandran S Vasan, et al.
Diabetes Care|September 28, 2005
Glycemic status and development of kidney disease: the Framingham Heart StudyCaroline S Fox, Martin G Larson, Eric P Leip, et al.
Circulation|June 25, 2003
Heritability and genetic linkage of plasma natriuretic peptide levelsThomas J Wang, Martin G Larson, Daniel Levy, et al.
Circulation|February 23, 2005
Predictors of new-onset diastolic and systolic hypertension: the Framingham Heart StudyStanley S Franklin, Jose R Pio, Nathan D Wong, et al.
JAMA|September 7, 2002
Plasma natriuretic peptides for community screening for left ventricular hypertrophy and systolic dysfunction: the Framingham heart studyRamachandran S Vasan, Emelia J Benjamin, Martin G Larson, et al.
Circulation|February 11, 2004
Impact of obesity on plasma natriuretic peptide levelsThomas J Wang, Martin G Larson, Daniel Levy, et al.
The American Journal of Cardiology|June 29, 2004
Framingham risk score and prediction of lifetime risk for coronary heart diseaseDonald M Lloyd-Jones, Peter W F Wilson, Martin G Larson, et al.
Pageof 3